Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep311 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Design of a Randomized Withdrawal Period Following Long-Term Administration of Diazoxide Choline Extended-Release Tablets to People with Prader-Willi Syndrome

Gevers Evelien , Bhatnagar Anish

Background: PWS is a rare genetic neurodevelopmental disorder characterized by hyperphagia, obesity, hormonal deficiencies, and problem behaviors for which there is no approved treatment. DESTINY PWS (C601) was an international, placebo-controlled, Phase 3 study of DCCR (diazoxide choline) extended-release tablet in participants with PWS, age 4 and older with hyperphagia. C602 is a long-term, open label extension to C601. DCCR administration to participants with PWS in these s...

ea0044p244 | Thyroid | SFEBES2016

TIGIT gene variants and thyroid disease susceptibility in dogs and humans

Bhatnagar Ishita , Massey Jonathan , Kennedy Lorna , Ollier William , Cordell Heather , Pearce Simon , Mitchell Anna

Background: The autoimmune thyroid diseases, primary autoimmune hypothyroidism (AH) and GravesÂ’ hyperthyroidism (GD), represent the most prevalent endocrine disorders. Although clinically distinct, they share several genetic susceptibility loci, many of which remain unidentified.TIGIT (T cell immunoreceptor with immunoglobulin and ITIM domains), expressed on the surface of T-cells, interacts with CD-155 on dendritic cells to form an alternative cost...

ea0056p453 | Diabetes complications | ECE2018

Endothelial dysfunction in the diabetic foot

Jude Edward , Mascarenhas Janice , Bhatnagar Deepak , Weston R , Wilkinson Fiona , Alexander Yvonne

Endothelial dysfunction (ED) is common in type 2 diabetes mellitus (T2DM) and can lead to microvascular and macrovascular complications. The aim of our study was to assess ED in patients with T2DM (n=21; 13 with diabetic neuropathy (DN), 8 without DN) and compare them with non-diabetic controls (n=10).Methods: ED was assessed by skin microcirculation (SM) and biochemical markers (BM) of endothelial function. SM was measured on the dorsu...

ea0056p455 | Diabetes complications | ECE2018

Bone markers and bone integrity in type 2 diabetes

Jude Edward , Mascarenhas Janice , Bhatnagar Deepak , Weston R , Wilkinson Fiona , Alexander Yvonne

Type 2 diabetes mellitus (T2DM) and obesity are linked to osteoporosis, making these patients at increased risk of developing fractures. In this study we aimed to investigate bone biochemical markers and bone structure in diabetic patients to compare with non-diabetic controls.Methods: We recruited 21 type 2 diabetic patients and 10 non-diabetic controls. Fasting blood samples were collected for markers of bone turnover (Sclerostin (SCL), RANKL, OPG, OPN...

ea0011p419 | Diabetes, metabolism and cardiovascular | ECE2006

Impact of migration on circulating adipocytokines in an Asian Indian population

Heald AH , Patel J , Prabharakan D , Anderson S , Hughes E , Vyas A , Bhatnagar D , Reddy S , Durrington P , Cruickshank JK

Introduction: Propensity to centripetal adiposity is an ethnic characteristic amongst South Asians, which may underlie the excess risk for both coronary heart disease (CHD) and diabetes in this population. Circulating levels of adipocytokines (hormones which include leptin, adiponectin, tumour necrosis factor (TNF-alpha)) and C-reactive protein (CRP) reflect the adipose tissues endocrine and metabolic activity, and are implicated in CHD.Methods: We compa...

ea0007oc33 | Diabetes and metabolism | BES2004

Dietary intake and the IGF-system: a study in two related populations with a markedly different dietary intake

Anderson S , Heald A , Vyas A , Siddals K , Patel J , Laing I , Bhatnagar D , Durrington P , Gibson J , Cruickshank J

IntroductionThe IGF-system has also been implicated in the pathogenesis of diabetes and cardiovascular disease. We report the effects of total energy intake on the IGF-system in two populations with a markedly different dietary macronutrient intake and cardiovascular event rate.MethodDietary macronutrient intake was measured in a specific Gujarati migrant community in Sandwell UK (n=205) compared with people ...

ea0011p420 | Diabetes, metabolism and cardiovascular | ECE2006

Migration to the UK results in significantly lower testosterone levels in South Asian men

Patel JV , Panja N , Prabharakan D , Anderson S , Vyas A , Bhatnagar D , Durrington P , Gibson JM , Hughes E , Reddy S , Cruickshank JK , Heald AH

Introduction: Compared to ethnically European men, Pakistani origin men living in the UK have a lower circulating total and free testosterone level, corresponding with greater central adiposity and higher insulin resistance. Within a South Asian group we have now examined the effect of migration to the UK on male testosterone level.Methods: Circulating testosterone concentration was measured by automated immunoassay in 97 Gujarati males resident in India...

ea0081p77 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparison of hyperphagia and problem behaviors in participants with prader-willi syndrome (PWS) receiving diazoxide choline extended-release (DCCR) with matched participants in PATH for PWS (PfPWS)

Gevers Evelien , Strong Theresa , Miller Jennifer , Felner Eric , Goldstone Tony , Bridges Nicola , Yanovski Jack , Bird Lynne , Butler Merlin , Obrynba Kathryn , Lah Melissa , Shoemaker Ashley , Mejia-Corletto Jorge , Stevenson David , Wilding John , Kimonis Virginia , Abuzzahab Jennifer , Konczal Laura , Mathew Verghese , Cowen Neil , Woloschak Michael , Bhatnagar Anish

Background: PWS is a rare neurodevelopmental genetic disorder characterized by hyperphagia, obesity, hormonal deficiencies, and problem behaviors for which there are no approved treatment. DCCR administration (100-525 mg/day) up to 52 weeks in participants with PWS improved hyperphagia, behavior, body composition and metabolic markers.Objective: The objective of this study was to compare changes in hyperphagia (using Hyperphagia Questionnaire for Clinica...

ea0081ep360 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Long-term safety of diazoxide choline extended-release (DCCR) tablets in patients with prader-willi syndrome

Gevers Evelien , Miller Jennifer , Butler Merlin , Bridges Nicola , Goldstone Tony , Obrynba Kathryn , Salehi Parisa , Felner Eric , Bird Lynne , Shoemaker Ashley , Konczal Laura , Lah Melissa , Yanovski Jack , Angulo Moris , Mejia-Corletto Jorge , Stevenson David , Wilding John , Abuzzahab Jennifer , Shaikh Guftar , Viskochil David , Mathew Verghese , Yen Kristen , Woloschak Michael , Bhatnagar Anish

Background: Prader-Willi syndrome (PWS), a rare genetic neurobehavioral-metabolic condition, is characterized by hyperphagia, accumulation of excess fat, hypotonia, and behavioral/psychological complications. There are no currently approved medications to treat hyperphagia in patients with PWS; DCCR is under development as a treatment for PWS.Objectives and Methods: The objective was to evaluate long-term safety of DCCR in individuals with PWS. 125 parti...